Last updated on December 2017

A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Subjects with Alzheimer’s Disease

Brief description of study

This is a study to test the safety and tolerability of the research study drug, suvorexant and test the effects of suvorexant compared to placebo in improving insomnia in subjects with mild to moderate Alzheimer’s disease.

Clinical Study Identifier: TX154876

Contact Investigators or Research Sites near you

Start Over

Todd Morgan

Texas Neurology, PA
Dallas, TX USA
  Connect »